1.33
Schlusskurs vom Vortag:
$1.39
Offen:
$1.38
24-Stunden-Volumen:
339.14K
Relative Volume:
0.55
Marktkapitalisierung:
$1.96M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1334
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-24.00%
1M Leistung:
-35.75%
6M Leistung:
-67.56%
1J Leistung:
-89.54%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Firmenname
60 Degrees Pharmaceuticals Inc
Sektor
Branche
Telefon
202-327-5422
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Vergleichen Sie SXTP mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SXTP
60 Degrees Pharmaceuticals Inc
|
1.33 | 2.58M | 502.40K | -7.91M | -4.32M | -9.972 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten
What analysts say about 60 Degrees Pharmaceuticals Inc. Equity Warrant stockFree Stock Chart Pattern Guide - jammulinksnews.com
60 Degrees Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastFree Trend-Following Techniques - jammulinksnews.com
What drives 60 Degrees Pharmaceuticals Inc. Equity Warrant stock priceBreakthrough capital growth - jammulinksnews.com
Is 60 Degrees Pharmaceuticals Inc. a good long term investmentTremendous wealth creation - jammulinksnews.com
What analysts say about 60 Degrees Pharmaceuticals Inc. stockHigh-profit trading signals - jammulinksnews.com
What drives 60 Degrees Pharmaceuticals Inc. stock priceConsistently high yield - jammulinksnews.com
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a good long term investmentExceptional market performance - Autocar Professional
60 Degrees Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding capital appreciation - Autocar Professional
Will 60 Degrees Pharmaceuticals Inc. stock benefit from interest rate changesHigh Return Stock Alerts - Newser
60 Degrees Pharmaceuticals Secures $5M in Recent Offering - TipRanks
How 60 Degrees Pharmaceuticals Inc. stock reacts to Fed policy changesFree Deep Market Trend Analysis - Newser
What risks could impact 60 Degrees Pharmaceuticals Inc. Equity Warrant stock performanceWealth Building Stock Portfolio - Newser
60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease By Investing.com - Investing.com India
60 Degrees Pharmaceuticals Initiates Study on Tafenoquine's Efficacy Against Lyme Disease and Bartonella Pathogens - Nasdaq
60 Degrees Pharmaceuticals and Tulane University Sign Research Agreement to Study Tafenoquine Against Lyme and Bartonella Bacteria - The Manila Times
60 Degrees Pharmaceuticals to study tafenoquine against Lyme disease - Investing.com
Major Breakthrough: Anti-Malaria Drug Tafenoquine Being Tested for Lyme Disease Treatment - Stock Titan
60 Degrees Pharmaceuticals' Warrant Gambit: Balancing Liquidity and Longevity - AInvest
60 Degrees Pharmaceuticals closes $5 million public offering By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals closes $5 million public offering - Investing.com Australia
60 Degrees Pharmaceuticals Secures $5 Million in Public Offering - AInvest
60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering - Stock Titan
Form 424B4 60 DEGREES PHARMACEUTICA - StreetInsider
Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):